Parkinson's Blog | Rengifo Parkinson's Foundation
-
Parkinson's Disease Test: Alpha-Synuclein Research Advances in 2026
Scientists can now detect misfolded alpha-synuclein, a hallmark of Parkinson's disease, in spinal fluid and even skin. Here's what 2026 research shows about these tests.
-
Stem Cell Therapy for Parkinson's: 2026 Clinical Trial Results Explained
Two stem cell trials for Parkinson's shared new results in 2026, including first-year data published in Nature Medicine. Here's what was found, and what is still unknown.
-
New Parkinson's Medication: FDA Approves Tavapadon (Juvmo) in 2026
In September 2026 the FDA approved tavapadon (Juvmo), a once-daily Parkinson's medication that works on dopamine receptors in a new way. Here's what families should know.